increased heart rate with tirzepatide UC Irvine researchers project cardiac benefits from weight-loss medication Tirzepatide, a dual GIP/GLP1-receptor co-agonist

Researchers continue to explore the best ways to maintain weight and health goals after losing weight with an anti-obesity drug

Linda Anegawa, M.D., chief of medicine at digital health company Noom, said medication alone is not the answer when some patients experience difficult side effects

Tirzepatide is administered via once or twice-weekly subcutaneous injections

What does PlexusDx semaglutide cost, and is it covered by insurance

Comprehensive evaluations and customized treatment plans designed around your unique weight loss goals

"We have not hit 15% in any other phase three trial for weight management in this type two diabetes population," said Dr